Jesse Schold, PhD

Staff

Lerner Research Institute
9500 Euclid Avenue
Cleveland, Ohio 44195
Location:JJN3-325
scholdj@ccf.org
Phone: (216) 444-6254
Fax: (216) 444-2781


In other words ...

Dr. Schold’s research interests include development and impact of quality metrics for healthcare providers, health services research, disparities in access to healthcare and statistical and epidemiological methods. He oversees the ongoing monitoring and quality evaluation of the solid organ transplantation programs at the Cleveland Clinic and has special interest in the development and use of report cards in transplantation. 


  1. Kaplan B, Schold J, Meier-Kriesche HU.  Overview of Large Database Analysis in Renal Transplantation. American Journal of Transplantation. 2003 Sep; 3(9):1052-6.
  2. Kaplan B, Schold JD, Meier-Kriesche HU.  Long-Term Graft Survival with Neoral and Tacrolimus: A Paired Kidney Analysis. Journal of the American Society of Nephrology. 2003 Nov; 14(11):2980-4.
  3. Kaplan B, Schold J, Meier-Kriesche HU. Poor Predictive Value of Serum Creatinine for Renal Allograft Loss. American Journal of Transplantation. 2003 Dec; 3(12):1560-5.
  4. Meier-Kriesche HU, Schold JD, Kaplan B. Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era. American Journal of Transplantation. 2004 Mar; 4(3):378-83.
  5. Reddy V, Iturraspe JA, Tzolas AC, Meier-Kriesche HU, Schold J, Wingard JR.  Low Dendritic Cell Count after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Relapse, Death, and Acute Graft-versus-host Disease. Blood. 2004 Jun 1; 1003(11):4330-5. 
  6. Meier-Kriesche HU, Schold JD, Kaplan B.  Long-term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?  American Journal of Transplantation. 2004 Aug; 4(8):1289-95.
  7. Kaplan B, Schold J, Srinivas T, Womer K, Foley DP, Patton P, Howard R, Meier-Kriesche HU.  Effect of Sirolimus Withdrawal in Patients with Deteriorating Renal Function.  American Journal of Transplantation. 2004 Oct: 4(10):1709-12.
  8. Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B.  Kidney Transplantation Halts Cardiovascular Disease Progression in Patients with End-Stage Renal Disease.  American Journal of Transplantation. 2004 Oct; 4(10):1662-8.
  9. Womer KL, Peng R, Patton PR, Kaleem A, Bucci M, Murawski MR, Schold J, Efron PA, Hemming AW, Srinivas TR, Meier-Kriesche HU, Kaplan B, Clare-Salzler MJ.  The Effects of Renal Transplantation on Circulating Precursor Dendritic Cells.  Transplant Proceedings. 2005 Jan-Feb; 37(1):3-6.
  10. Meier-Kriesche HU, Schold JD, Kaplan B.  Preservation of Long-Term Renal Allograft Survival:  A Challenge for the Years to Come. (letter to the editor)  American Journal of Transplantation. 2005 Mar; 5(3):632-3.
  11. Koc M, Richards HB, Bihorac A, Ross EA, Schold JD, Segal MS.  Correlating CEC Number with Cardiovascular Events and Markers of Inflammation and Endothelial Dysfunction.  Kidney International. 2005 Mar; 67(3):1078-83.
  12. Reed A, Howard RJ, Fujita S, Foley DP, Langham MR, Schold JD, Nelson D, Soldevila-Pico R, Abdelmalek M, Morrelli G, Hemming AW.  Liver retransplantation:  a single-center outcome and financial analysis.  Transplant Proceedings.  2005 Mar; 37(2): 1161-3.
  13. Schold JD, Kaplan B, Baliga RS, Meier-Kriesche HU.  The Broad Spectrum of Quality in Deceased Donor Kidneys.  American Journal of Transplantation.  2005 Apr; 5(4):757-65.
  14. Meier-Kriesche HU, Schold JD, Gaston RS, Wadstrom J, and Kaplan B.  Kidneys from Deceased Donors: Maximizing the Value of a Scarce Resource.  American Journal of Transplantation. 2005 Jul; 5(7):1725-30.
  15. Schold JD, Kaplan B, Howard RJ, Reed AI, Foley DP, Meier-Kriesche HU.  Are we Frozen in Time?  Analysis of the Utilization and Efficacy of Pulsatile Perfusion in Renal Transplantation.  American Journal of Transplantation. 2005 Jul; 5(7):1681-8.
  16. Howard RJ, Schold J, Cornell, D.  A 10-year analysis of Organ Donation after Cardiac Death in the United States.  Transplantation. 2005 Sep 15; 80(5):564-8.
  17. Womer KL, Peng R, Patton PR, Murawski MR, Bucci M, Kaleem A, Schold J, Efron PA, Hemming AW, Srinivas TR, Meier-Kriesche HU, Kaplan B, Clare-Salzler MJ. The Effects of Renal Transplantation on Peripheral Blood Dendritic Cells. Clinical Transplant. 2005 Oct; 19(5):659-67.
  18. Schold JD, Kaplan B, Chumbler N, Howard RJ, Srinivas TR, Ma L, Meier-Kriesche HU.  Access to Quality:  Evaluation of the Allocation of Deceased Donor Kidneys for Transplantation.  Journal of the American Society of Nephrology. 2005 Oct; 16(10):3121-3127.
  19. Reddy V, Meier-Kriesche HU, Greene S, Schold JD, Wingard JR.  Increased Levels of Tumor Necrosis Factor alpha are Associated with an Increased Risk of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.  Biology of Blood and Marrow Transplantation. 2005 Sep; 11(9):698-705.
  20. Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, and Kaplan B.  Sirolimus in combination with Tacrolimus is associated with worse renal allograft survival compared to Mycophenalate Mofetil and Tacrolimus.  American Journal of Transplantation. 2005 Sep; 5(9):2273-80. 
  21. Srinivas TR, Kaplan B, Schold JD, and Meier-Kriesche HU.  The Impact of Mycophenalate Mofetil on Long-Term Outcomes in Kidney Transplantation.  Transplantation.  2005 Oct 15; 80(2 Suppl):S211-20.
  22. Reddy V, Winer AG, Eksioglu E, Meier-Kriesche HU, Schold JD, and Wingard JR.  Interleukin-12 (IL-12) is associated with reduced relapse after allogeneic Hematopoietic stem cell transplantation.  Biology of Blood and Marrow Transplantation. 2005 Dec; 11(12):1014-1021.
  23. Meier-Kriesche HU and Schold JD.  The Impact of Pre-Transplant Dialysis on Outcomes in Renal Transplantation.  Seminars in Dialysis. 2005 Nov-Dec; 18(6): 499-504. 
  24. Schold JD and Howard RJ.  Assessing Transplant Center Performance:  Can a Little Knowledge be a Dangerous Thing?  (Editorial)  American Journal of Transplantation.  2006 Feb; 6(2): 245-6.
  25. Womer KL, Schold JD, and Meier-Kriesche HU.  Renal Transplantation in the Elderly.  Aging Health.  2006 Feb; 2(1): 145-52. 
  26. Srinivas TR, Schold JD, Womer KL, Kaplan B, Howard RJ, Bucci CM, and Meier-Kriesche HU.  Improvement in Hypercalcemia Post-Kidney Transplantation with Cinacalcet.  Clinical Journal of the American Society of Nephrology.  2006 March; 1(2):  323-26.
  27. Schold JD and Meier-Kriesche HU.  Which Renal Transplant Candidates Should Accept Marginal Kidneys in Exchange for Shorter Waiting Time on Dialysis?  Clinical Journal of the American Society of Nephrology. 2006 May; 1(3):  532-38.   
  28. Lansang MC, Ma L, Schold JD, Meier-Kriesche HU, Kaplan B.  Relationship between Diabetes and Infectious Hospitalizations in Renal Transplant Recipients. Diabetes Care. 2006 July; 29(7): 1659-1660.
  29. Srinivas TR, Schold JD, Meier-Kriesche HU.  Mycophenolate mofetil: Long-term outcomes in solid organ transplantation.  Expert Review of Clinical Immunology. 2006 July; 2(4): 495-518.     
  30. Schold JD, Howard RJ, Scicchitano MJ, and Meier-Kriesche HU.  The Expanded Criteria Donor Policy: An Evaluation of Program Objectives and Indirect Ramifications. American Journal of Transplantation. 2006 July; 6(7):  1689-95. 
  31. Schold JD,Srinivas TR, Guerra G, Reed AI, Johnson RJ, Weiner ID, Oberbauer R, Harman JS, Hemming AW, and Meier-Kriesche HU.  A “Weight-Listing” Paradox in Management of Candidates for Renal Transplantation?  American Journal of Transplantation. 2007 March; 7(3):  550-59.
  32. Srinivas TR, Schold JD, Guerra G, Bucci CM, Eagan A, and Meier-Kriesche HUMycophenalate Mofetil/Sirolimus Compared to other Common Immunosuppressive Regimens in Kidney Transplantation. American Journal of Transplantation.2007 March; 7(3):  586-94.
  33. Meier-Kriesche HU, Schold JD, and Ekberg HInterventional trials involving patients cannot be performed safely without a control group treated with the standard of care.  Transplantation. 2007 April; 27; 83(8):1137.
  34. Scornik JC, Guerra G, Schold JD, Srinivas TR, Dragun D, and Meier-Kriesche HU.  Value of post- transplant antibody tests in the evaluation of patients with renal graft dysfunction. American Journal of Transplantation. 2007 Jul; 7(7):1808-14.
  35. Schold JD, Meier-Kriesche HU, Duncan RP, and Reed AI.  Deceased Donor Kidney and Liver Transplantation to Non-Resident Aliens in the United States.  Transplantation. 2007 Dec; 84(12): 1548-56.
  36. Schold JD, Srinivas TR, Kayler LK and Meier-Kriesche HU.  The Overlapping Risk Profile between Dialysis Patients Listed and Not Listed for Renal Transplantation. American Journal of Transplantation. 2008 Jan; 8(1):58-68.
  37. Schold JD, Srinivas TR, Howard RJ, Jamieson I and Meier-Kriesche HU.  The Association of Candidate Mortality Rates with Kidney Transplant Outcomes and Center Performance Evaluations.  Transplantation. 2008 Jan; 85(1): 1-6.
  38. Kaplan B and Schold JD.  The Practical Utility of an Economic Evaluation of Calcineurin Inhibitor Withdrawal. Journal of the American Society of Nephrology. 2008 Sep; 19: 1627-1628.
  39. Schold JD and Kaplan B. Design and Analysis of Clinical Trials in Transplantation: Principles and Pitfalls.  American Journal of Transplantation. 2008 Sep; 8(9): 1779-85.
  40. Buzzeo MP, Dunbar EM, Levine JB, Schold JD, Meier-Kriesche HU, Reddy V. Circulating NK cells after reduced intensity hematopoetic stem-cell transplantation are associated with improved relapse free survival without increase in GVHD. Haematologica. 2008 Dec; 93(12):1852-8.
  41. Schold JD. Evaluation Criteria for Report Cards of Healthcare Providers. Advances in Health Economics and Health Services Research. 2008; 19: 173-89.
  42. Kayler LK, Magliocca J, Fujita S, Kim RD, Zendejas I, Hemming AW, Howard R, Schold JD. Recovery Factors Affecting Utilization of Small Pediatric Donor Kidneys. American Journal of Transplantation. 2009 Jan; 9(1): 210-16.
  43. Kayler LK, Garzon P, Magliocca J, Fujita S, Kim RD, Hemming AW, Howard R, Schold JD. Outcomes and Utilization of Kidneys from Deceased Donors with Acute Kidney Injury. American Journal of Transplantation. 2009 Feb; 9(2): 367-73.
  44. Schold JD, Harman JS, Chumbler NR, Duncan RP, Meier-Kriesche HU.  The Pivotal Impact of Center Characteristics on Survival of Candidates Listed for Deceased Donor Kidney Transplantation. Medical Care. 2009 Feb; 47(2): 146-53.
  45. Kaplan B and Schold J. Neural Networks for Predicting Graft Survival. Nature Reviews Nephrology. 2009 Apr; 5(4): 190-2.
  46. Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, Layon AJ, Segal MS. Long-term Risk of Mortality and Acute Kidney Injury during Hospitalization after Major Surgery.  Annals of Surgery. 2009, May; 249(5): 851-58.
  47. Scornik J, Schold JD, Bucci M, Meier-Kriesche HU. Effects of Transfusions given after Renal Transplantation. Transplantation. 2009 May; 87(9): 1381-86.
  48. Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon J, Bihorac A. Acute Kidney Injury is an Important Determinant of Long Term Survival after Cardiothoracic Surgery. Circulation. 2009 May; 119(18): 2444-53.
  49. Schold JD, Rehman S, Kayler LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK Virus: Incidence, Risk Factors and Outcomes for Kidney Transplant Recipients in the United States. Transplant International. 2009 June; 22(6): 626-34.
  50. Meier-Kriesche HU, Scornik J, Susskind B, Rehman S, Schold JDA Lifetime Versus a Graft Life approach redefines the Importance of HLA Matching in Kidney Transplant Patients. Transplantation. 2009 July; 88(1): 23-29.
  51. Schold J, Srinivas TR, Sehgal AR, Meier-Kriesche HU. Half of Kidney Transplant Candidates over the age of Sixty now Placed on the Waiting List will Die prior to receiving a Deceased Donor Transplant. Clinical Journal of the American Society of Nephrology. 2009 July; 4(7): 1239-45.
  52. Schold JD and Meier-Kriesche HU. Comparable Barriers to Access to Kidney Transplantation across National Lines. Transplantation. 2009 July; 88(1): 21-22.
  53. Ejaz AA, Beaver TM, Shimada M, Sood P, Lingegowda V, Schold JD, Kim T, Johnson RJ.  Uric Acid: A Novel Risk Factor for Acute Kidney Injury in High Risk Cardiac Surgery Patients? American Journal of Nephrology. 2009 Sep; 30(5): 425-29.
  54. Schold JD and Kaplan B. AZA/Tacrolimus is associated with similar outcomes as MMF/Tacrolimus among renal transplant recipients. American Journal of Transplantation. 2009 Sep; 9(9): 2067-74.
  55. Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Uric Acid Levels have no Significant Effect on Renal Function in Adult Renal Transplant Recipients: Evidence from the Symphony Study. Clinical Journal of the American Society of Nephrology. 2009 Oct; 4(10): 1655-60. 
  56. Kayler LK, Magliocca J, Kim RD, Howard R, Schold JD. Single Kidney Transplantation from Young Pediatric Donors in the United States. American Journal of Transplantation. 2009 Dec; 9(12): 2745-51.
  57. Howard RJ, Cornell D, Schold JD. CMS, OPOs and Transplant Centers and the Law of Unintended Consequences. Clinical Transplantation. 2009 Nov-Dec; 23: 778-83.
  58. Estrada AH, Maisenbacher HW, Prosek R, Schold J, Powell M, VanGilder JM. Evaluation of Pacing Site in Dogs with Naturally Occurring Complete Heart Block. Journal of Veterinary Cardiology. 2009 Dec; 11(2):79-88.
  59. Schold JD, Santos A, Rehman S, Magliocca J, Meier-Kriesche HU. The Success of Continued Steroid Avoidance after Kidney Transplantation in the United States. American Journal of Transplantation. 2009 Dec; 9(12): 2768-2776.
  60. Navaneethan SD, Schold JD, Srinivas TR. Metabolic Syndrome and Mild to Moderate Chronic Kidney Disease among Minorities. Seminars in Nephrology. 2010 Jan; 30(1): 51-58.
  61. Cable C, Buzzeo M, Schold J, Khan S, Leather H, Moreb J, Jamieson K, Scornik J, Amdur RJ, Wingard JR, Reddy V. Reduced intensity conditioning using fludarabine with either anti-thymocyte globulin and busulfan, or low dose total body irradiation allowing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 2010 Jan; 45(1):31-37.
  62. Bihorac A, Schold JD, Hobson CE. Long-term Mortality Associated With Acute Kidney Injury Requiring Dialysis. Journal of the American Medical Association. 2010 Jan; 303(3):229-230.
  63. Perez-Pozo SE, Schold J, Nakagawa T, Sanchez-Lozada LG, Johnson RJ, Lillo JL. Excessive Fructose Intake Induces Features of Metabolic Syndrome in Healthy Adult Males: Role of Uric Acid in the Hypertensive Response. International Journal of Obesity. 2010 Mar; 34(3):454-61.
  64. Guerra G, Indahyung R, BucciCM, ScholdJD, Magliocca J, Meier-Kriesche HU. Elevated incidence of post-transplant erythrocytosis after simultaneous kidney pancreas transplantation. American Journal of Transplantation. 2010 Apr; 10(4): 938-42.
  65. Bihorac A, Schold JD, Hobson CE. Acute Kidney Injury and Long-Term Outcomes: More to Learn. Kidney International. 2010 Apr; 77(8): 75.
  66. Schold JD and Kaplan B. The Elephant in the Room: Failings of Current Clinical End Points in Kidney Transplantation. American Journal of Transplantation. 2010 May; 10(5): 1163-66.
  67. Bihorac A, Delano MJ, Schold JD, Lopez MC, Nathens AB,  Maier RV, Layon AJ, Baker HV, Moldawer LL. Incidence, clinical predictors, genomics, and outcome of acute kidney injury among trauma patients. Annals of Surgery. 2010 Jul; 252(1):158-65.
  68. Kayler LK, Magliocca J, Kim RD, Schold JD. Letter to the Editor: Single Kidney Transplantation from Young Pediatric Donors in the United States. American Journal of Transplantation. 2010 Sep; 10(9): 2180.
  69. Schold JD, Sehgal AR, Srinivas TR, Poggio ED, Navaneethan SD, Kaplan B. Marked Variation of the Association of ESRD Time before and after Wait Listing on Transplant Outcomes. American Journal of Transplantation. 2010 Sep; 10(9): 2008-16.
  70. Schold JD, Arrington CJ, Levine G. Significant Alterations in Reported Clinical Practice associated with Increased Oversight of Organ Transplant Center Performance. Progress in Transplantation. 2010 Sep; 20(3): 279-87.
  71. Schold JD, Srinivas TR, Poggio ED, Stephany BR, Flechner SM, Goldfarb DA, Kattan MW. Hidden Selection Bias Deriving from Donor Organ Characteristics does not affect Performance Evaluations of Kidney Transplant Centers. Medical Care. 2010 Oct; 48(10):907-14.
  72. Kayler LK, Schold JD, Magliocca JF. DonorNet and the Potential Effects on Organ Utilization. American Journal of Transplantation. 2010 Oct; 10(10): 2376.
  73. Srinivas TR, Stephany BR, Budev M, Mason D, Miller C, Starling R, Goldfarb D, Flechner S, Poggio E, Schold JD. An Emerging Population: Waitlisted Kidney Candidates after Liver, Heart and Lung Transplantation. Clinical Journal of the American Society of Nephrology. 2010 Oct; 5(10): 1881-86.
  74. Schold JD and Hall YN. Enhancing the Expanded Criteria Donor Policy as an Intervention to Improve Kidney Allocation: Is it actually a “net-zero” model? American Journal of Transplantation. 2010 Dec; 10(12): 2582-85.
  75. Srinivas TR, Flechner SM, Poggio ED, Askar M, Goldfarb DA, Navaneethan SD, Schold JD. GFR Slopes have significantly improved among Renal Transplants in the United States. Transplantation. 2010 Dec 27; 90(12): 1499-1505.
  76. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, Lyons J, Simon JF, Schreiber MJ, Jain A, Nally JV. Development and Validation of an Electronic Health Record based Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 2011 Jan; 6(1): 40-49.
  77. Kandula P, Dobre M, Schold J, Schreiber MJ,Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis. Clinical Journal of the American Society of Nephrology. 2011 Jan; 6(1): 50-62.
  78. Kayler LK, Sokolich J, Magliocca J, Schold JD. Import Kidney Transplants from Non-Mandatory Share Deceased Donors: Characteristics, Distribution and Outcomes. American Journal of Transplantation. 2011 Jan; 11(1): 77-85.
  79. Conversion from Diagnostic Laparoscopy to Laparotomy: Risk Factors and Occurrence. Boute NJ, Kovak-McClaran JR, Schold JD. Veterinary Surgery. 2011 Jan; 40(1): 106-14.
  80. Braun WE and Schold JD. Strength in Numbers – Predicting Renal Transplant Success. Nature Reviews Nephrology. 2011 Mar; 7(3): 135-6.
  81. Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ, Nally JV. Implications of the CKD-EPI Estimation Equation in Clinical Practice. Clinical Journal of the American Society of Nephrology. 2011 Mar; 6(3): 497-504.
  82. Segev DL, Massie AM, Schold JD, Kaplan B. If You’re Not Fit, You Mustn’t Quit: Observational Studies and Weighing the Evidence.  American Journal of Transplantation. 2011 Apr; 11(4): 652-53.
  83. Response to Dr. White. Perez-Pozo SE, Schold J, Nakagawa T, Sanchez-Lozada LG, Johnson RJ, Lopez-Lillo J. International Journal of Obesity. 2011 May; 35(5): 748-9.
  84. Askar M, Schold JD, Eghtesad B, Flechner SM, Kaplan B, Klingman L, Zein N, Fung J, Srinivas TR. Combined Liver-Kidney Transplants: Allosensitization and Recipient Outcomes. Transplantation. 2011 June; 15; 91(11): 1286-92.
  85. Schold JD, Buccini LD, Goldfarb DA, Flechner SM, Hsich E, Mason D, Fung J, Stephany BR, Krishnamurthi V, Srinivas TR. Patient Participation in Research among Solid Organ Transplant Recipients in the United States. Transplantation. 2011 June 27; 91(12): 1424-35.
  86. Schold JD, Gregg JA, Harman JS, Hall AG, Patton P, Meier-Kriesche HU. Barriers to Evaluation and Wait Listing for Kidney Transplantation. Clinical Journal of the American Society of Nephrology. 2011 July 6(7); 1760-67.
  87. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ, Simon JF, Srinivas TR, Nally JV. 25-hydroxy vitamin D deficiency, body mass index, race and mortality in chronic kidney disease. American Journal of Kidney Disease. 2011 Oct; 58(4): 536-43. 
  88. Schold JD and Goldfarb DA. Significant Potential Utility for Donor Yield Models:  But Proceed with Caution. American Journal of Transplantation. 2011 Oct; 11(10): 2009-11.  
  89. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ, Nally JV. Serum Bicarbonate and Mortality in Stage 3 and Stage 4 Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 2011 Oct; 6(10): 2395-402.
  90. Schold JD, Srinivas TR, Braun WE, Shoskes DA, Nurko S, Poggio ED. The Relative Risk of Overall Graft Loss and Acute Rejection among African American Renal Transplant Recipients is Attenuated with Advancing Age. Clinical Transplantation. 2011 Sep/Oct; 25(5): 721-730.  
  91. Demirijian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ. Hypophosphatemia during Continuous Renal Replacement Therapy is associated with Prolonged Respiratory Failure in Patients with Acute Kidney Injury.  Nephrology Dialysis Transplantation. 2011 Nov; 26(11): 3508-14.
  92. Kayler LK, Magliocca J, Zendejas I, Kandaswamy R, Srinivas TR, Schold JD. Impact of Cold Ischemia Time on Graft Survival among ECD Transplant Recipients:  A Paired Kidney Analysis. American Journal of Transplantation. 2011 Dec; 11(12): 2647-56.
  93. Kayler LK, Srinivas TR, Schold JD. Influence of CIT-Induced DGF on Kidney Transplant Outcomes. American Journal of Transplantation. 2011 Dec; 11(12): 2657-64.
  94. Claes K, Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Effect of different Immunosuppressive Regimens on the Evolution of Distinct Metabolic Parameters: Evidence from the Symphony Study. Nephrology Dialysis Transplantation. 2012 Feb;27(2):850-7.
  95. Demirjian S, Schold JD, Navia J, Mastracci TM, Paganini EP, Yared J, Bashour CA. Predictive Models for Acute Kidney Injury following Cardiac Surgery. American Journal of Kidney Disease. 2012 Mar; 59(3): 382-9.
  96. Schold JD and Segev DL. Increasing the Pool of Deceased Donor Organs for Kidney Transplantation. Nature Reviews Nephrology. 2012 June; 8(6):325-31.
  97. Schold JD, Buccini LD, Kattan MW, Goldfarb DA, Flechner SM, Srinivas TR, Poggio ED, Fatica R, Kayler LK, Sehgal AR. The Association of Community Health Indicators with Outcomes for Kidney Transplant Recipients in the United States. Archives of Surgery. 2012; June; 147(6): 520-26.
  98. Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ, Nally JV. Serum Triglycerides and Risk for Death in Non-Dialysis Dependent Chronic Kidney Disease. Nephrology, Dialysis and Transplantation. 2012 Aug; 27(8): 2338-34.
  99. Fissell R, Srinivas TR, Fatica R, Nally J, Navaneethan S, Poggio E, Goldfarb D, Schold J. Preemptive Renal Transplant Candidate Survival, Access to Care, and Renal Function at Listing. Nephrology, Dialysis and Transplantation. 2012 Aug: 27(8): 3321-9.
  100. Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sarnak MJ, Schold JD. Obesity, Anthropometric Measures and Chronic Kidney Disease Complications. American Journal of Nephrology. 2012 Aug; 26(3): 219-27.
  101. Wilson DA, Yen-Lieberman B, Schindler S, Asamoto K, Schold JD, Procop GW.  Should Varicella-Zoster Virus Culture be Eliminated? A Comparison of DFA, Culture, and PCR with a Historical Review. Journal of Clinical Microbiology. 2012 Dec; 50(12): 4120-2.
  102. Navaneethan SD, Kirwan JP, Arrigain S, Sehgal AR, Schold JD. Diet, Physical activity, Obesity and Intentional Weight Loss in Chronic Kidney Disease: NHANES 1999-2006. International Journal of Obesity. 2012 Dec; 36(12): 1585-90.
  103. Schold JD, Buccini LD, Srinivas TR, Srinivas RT, Poggio ED, Flechner SM, Soria C, Segev DL, Fung J, Goldfarb DA. The Association of Center Performance Evaluations and Kidney Transplant Volume in the United States. American Journal of Transplantation. 2013 Jan; 13(1): 67-75.
  104. Thornton JD, Schold JD, Venkateshaiah L, Lander B. The Prevalence of Copied Information by Attendings and Residents in Critical Care Progress Notes. Critical Care Medicine. 2013 Feb; 41(2): 382-8.
  105. Navaneethan SD, Jolly SE, Sharp J, Jain A, Schold JD, Schreiber MJ, Nally JV. Electronic Health Records: A New Tool to Combat Kidney Disease? Clinical Nephrology. 2013 Mar; 79(3): 175-83.
  106. Grams ME, Massie AB, Schold JD, Chen BP, Segev DL. Trends in the inactive kidney transplant waitlist and implications for candidate survival. American Journal of Transplantation. 2013 Apr: 13(4): 1012-18.
  107. Heaphy ELG, Goldfarb DA, Poggio ED, Buccini LD, Flechner SM, Schold JD. The Impact of Deceased Donor Kidney Risk Significantly Varies by Recipient Characteristics. American Journal of Transplantation. 2013 Apr; 13(4): 1001-11. 
  108. Braun WE, Protiva DA, Schold JD. Decreased Total CD19+ B Lymphocytes and the Occurrence of Monoclonal Proteins are Frequent in Ultra-Long (30-44 Year) Renal Transplant Recipients: Implications for Allograft and Patient Survival. Transplant Proceedings. 2013 May; 45(4): 1466-68.
  109. Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Poggio ED, Beddhu S, Nally JV. Metabolic Syndrome, End Stage Renal Disease and Death in Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 2013 June; 8(6): 945-52.  
  110. Schold JD, Buccini LD, Heaphy E, Goldfarb DA, Sehgal AR, Fung J, Poggio ED, Kattan MW. The Prognostic Value of Kidney Transplant Center Report Cards. American Journal of Transplantation. 2013 July; 13(7): 1703-12.
  111. Schold JD. The Burden of Proof in the Design of Early Phase Clinical Trials. American Journal of Transplantation. 2013 July; 13(7): 1631-32.
  112. Elfadawy N, Flechner SM, Liu X, Schold J, Fatica R, Srinivas TR, Poggio E, Avery RK, Mossad SB. The Impact of Surveillance and Rapid Reduction in Immunosuppression to Control BK Virus Related Graft Injury in Kidney Transplantation.  Transplant International. 2013 Aug; 26(8): 822-32.
  113. Ohashi Y, Thomas G, Nurko S, Stephany B, Fatica R, Rule AD, Srinivas T, Schold JD, Navaneethan SD, Poggio ED. Association of Metabolic Syndrome with Kidney Function and Histology in Living Kidney Donors. American Journal of Transplantation. 2013 Sep; 13(9): 2342-51.
  114. Schold JD, Heaphy ELG, Buccini LD, Poggio ED, Srinivas TR, Goldfarb DA, Flechner SM, Rodrigue JR, Thornton JD, Sehgal AR. Prominent Impact of Community Risk Factors on Kidney Transplant Candidate Processes and Outcomes. American Journal of Transplantation. 2013 Sep; 13(9): 2374-83.
  115. Zachariah M, Gregg A, Schold J, Magliocca J, Kayler LK. Alemtuzumab Induction in Simultaneous Pancreas and Kidney Transplantation. Clinical Transplantation. 2013 Sep; 27(5): 693-700.
  116. Sakhuja A, Schold JD, Kumar G, Dall A, Sood P, Navaneethan SD. Outcomes of Patients on Maintenance Dialysis  Admitted Over Weekends. American Journal of Kidney Disease. 2013 Oct; 62(4): 763-70.
  117. Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G, Nally JV, Navaneethan SD. Prognostic Importance of Serum Alkaline Phosphatase in CKD Stages 3-4 in a Clinical Population. American Journal of Kidney Disease. 2013 Oct; 62(4): 703-10.
  118. Kayler LK, Wen X, Zachariah M, Casey M, Schold J, Magliocca J. Outcomes and Survival Analysis of Old-to-Old Simultaneous Pancreas and Kidney Transplantation. Transplant International. 2013 Oct; 26(10): 963-72.
  119. Schold JD, Goldfarb DA, Buccini LD, Rodrigue JR, Mandelbrot DA, Heaphy ELG, Fatica R, Poggio ED. Comorbidity Burden and Perioperative Complications for Living Kidney Donors in the United States. Clinical Journal of the American Society of Nephrology. 2013 Oct; 8(10): 1773-82.
  120. Thornton JD and Schold JD. Author Reply: The Association between Disease Severity and Copying Prevalence. Critical Care Medicine. 2013 Nov; 41(11), p.e395-96.
  121. Rodrigue JR, Schold JD, Mandelbrot DA. The Decline in Living Kidney Donation in the United States: Random Variation or Cause for Concern? Transplantation. 2013 Nov; 96(9): 767-773.
  122. Elfadaway N, Flechner SM, Liu X, Schold J, Srinivas T, Poggio E, Fatica R, Avery R, Mossad SB. CMV Viremia is Associated with a Decreased Incidence of BKV Reactivation after Kidney and Kidney-Pancreas Transplantation. Transplantation. 2013 Dec; 96(12): 1097-103.
  123. Van Duin D, Avery RK, Hemachandra S, Ye-Lieberman B, Zhang A, Jain A, Butler RS, Barnard J, Schold JD, Fung J, Askar M. KIR and HLA Interaction Predict CMV Viremia in High-Risk Solid Organ Transplant Recipients. American Journal of Transplantation. 2014 Jan; 14(1): 156-62.
  124. Buccini LD and Schold JD. Considerations of Reliability and Validity of Transplant Center Report Cards. American Journal of Transplantation. 2014 Jan; 14(1): 239-40.
  125. Sakhuja A, Schold JD, Kumar G, Katzan I, Navaneethan SD. Non-Traumatic Subarachnoid Hemorrhage in Maintenance Dialysis Hospitalizations: Trends and Outcomes. Chest. 2014 Jan; 45(1): 71-6.
  126. Prakash S, Coffin R, Schold J, Lewis SA, Gunzler D, Stark S, Howard M, Rodgers D, Einstadter D, Sehgal AR. Travel Distance and Home Dialysis Rates in the United States. Peritoneal Dialysis International. 2014 Jan; 34(1):24-32.
  127. Schold JD, Goldfarb DA, Buccini LD, Rodrigue JR, Mandelbrot DA, Heaphy ELG, Fatica R, Poggio ED. Hospitalizations following Living Donor Nephrectomy in the United States. Clinical Journal of the American Society of Nephrology. 2014 Feb; 9(2): 355-65.
  128. Elfadaway N, Flechner SM, Schold JD, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. Transient vs. Persistant BK Viremia and Long-term Outcomes after Kidney and Kidney-Pancreas Transplantation. Clinical Journal of the American Society of Nephrology. 2014 Mar: 9(3): 553-61.
  129. Kayler LK, Wen X, Zacharai M, Casey M, Schold J, Magliocca J. Response: Old-to-Old Pancreas Transplantation, What’s Old in the US may be Young in Europe. Transplant International. 2014 Apr; 27(4): e33.  
  130. Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DA, Tangri N, Shafi T, Wu AW, Bandeen-Roche K. Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced Chronic Kidney Disease. American Journal of Kidney Disease. 2014 May; 63(5): 806-15.
  131. Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai O, Arrigain S, Nally JV, Schold JD, Rahman M, Dweik R. Presence and Outcomes of Kidney Disease in Patients with Pulmonary Hypertension. Clinical Journal of the American Society of Nephrology. 2014 May; 9(5): 955-63.
  132. Braun WE, Schold JD, Stephany BR, Spirko RA, Herts BR. Low Dose Rapamycin (Sirolimus) Effects in Autosomal Dominant Polycystic Kidney Disease: An Open-Label Randomized Control Pilot Study. Clinical Journal of the American Society of Nephrology. 2014 May; 9(5): 881-88.
  133. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Sharp JW, Jain AK, Schreiber MJ, Simon JF, Nally JV. CKD in an Electronic Health Record Problem List: Quality of Care, ESRD and Mortality. American Journal of Nephrology. 2014 May; 39: 288-96.
  134. Heaphy ELG, Poggio ED, Flechner SM, Goldfarb DA, Askar M, Fatica R, Srinivas TR, Schold JD. Risk Factors for Retransplant Kidney Recipients: Outcomes from Patients’ Primary Transplant. American Journal of Transplantation. 2014 June; 14(6): 1356-67.
  135. Schold JD and Axelrod DA. Changing our Prior Assumptions: Adapting to the New Bayesian Transplant Center Report Cards. American Journal of Transplantation. 2014 June; 14(6): 1231-3.
  136. Sakhuja A, Stephany B, Deitzer D, Kumar G, Schold JD. Racial Disparity in Pulmonary Embolism Pre and Post Kidney Transplant. Transplant Proceedings. 2014 June; 46: 1353-61.
  137. Navaneethan SD, Sakhuja A, Arrigain S, Sharp J, Schold JD, Nally JV. Practice Patterns of Phosphate Binders and their Associations with Mortality in Chronic Kidney Disease. Clinical Nephrology. 2014 July; 82(7): 16-25.
  138. Navaneethan SD, Kirwan JP, Arrigain S, Schold JD. Adiposity Measures, Lean Body Mass, Physical Activity and Mortality: NHANES 1999-2004. BMC Nephrology. 2014 July 8; 15: 108.
  139. Schold JD and Reese PP. Simulating the New Kidney Allocation Policy in the United States: Modest Gains and Many Unknowns. Journal of the American Society of Nephrology. 2014 Aug; 25(8): 1617-9.
  140. Hsich EM, Starling RC, Blackstone EH, Singh TP, Young JB, Gorodeski EZ, Taylor DO, Schold JD. Does the UNOS Heart Transplant Allocation System Favor Men over Women? Journal of the American College of Cardiology: Heart Failure. 2014 Aug; 2(4): 347-55.
  141. Buccini LD, Segev DL, Fung J, Miller C, Kelly D, Quintini C, Schold JD. Association between Liver Transplant Center Performance Evaluations and Transplant Volume. American Journal of Transplantation. 2014 Sep; 14(9): 2097-2105.
  142. Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA. Serum Testosterone Levels and Mortality in Men With Stages 3-4 CKD. American Journal of Kidney Disease. 2014 Sep; 64(3): 367-74.
  143. Shoskes DA, Kerr H, Askar M, Goldfarb DA, Schold JD. Low Testosterone at Time of Transplant Independently Predicts Poor Patient and Graft Survival in Male Renal Transplant Recipients. Journal of Urology. 2014 Oct; 192(4): 1168-71.
  144. Schold JD, Buccini LD, Goldfarb DA, Flechner SM, Poggio ED, Sehgal AR. Association between Kidney Transplant Center Performance and the Survival Benefit of Transplantation versus Dialysis. Clinical Journal of the American Society of Nephrology. 2014 Oct 9: (10) 1773-80.  
  145. Opelami O, Sakhuja A, Liu X, Tang WHW, Schold JD, Navaneethan SD. Outcomes of Infected Cardiovascular Implantable Devices in Maintenance Dialysis Patients. American Journal of Nephrology. 2014 Oct 40: 280-87.
  146. Scialla JJ, Liu J, Crews DC, Guo H, Bandeen-Roche K, Ephraim PL, Tangri N, Sozio SM, Shafi T, Miskulin DC, Michels WM, Jarr BG, Wu AW, Powe NR, Boulware LE. An Instrumental Variable Approach Finds No Associated Harm or Benefit with Early Dialysis Initiation in the United States. Kidney International. 2014 Oct; 86(4): 798-809.
  147. Sugihara T, Hideo Y, Hiromasa H, Kiyohide F, Dalton J, Schold J, Kattan M, Yokio H. Performance Comparisons in Major Uro-Oncological Surgeries between the United States and Japan. International Journal of Urology. 2014 Nov 21(11): 1145-50.
  148. Rodrigue JR, Paek MJ, Egbuna O, Waterman AD, Schold JD, Pavlakis M, Mandelbrot DA. Making House Calls Increases Living Donor Inquiries and Evaluations for Blacks on the Kidney Transplant Waiting List. Transplantation. 2014 Nov 15;98(9): 979-86.
  149. Schold JD, Buccini LD, Reese PP, Poggio ED, Goldfarb DA. Effect of Dialysis Initiation for Preemptively Listed Candidates in the Revised Kidney Allocation Policy. American Journal of Transplantation. 2014 Dec 14(12): 2855-60.
  150. Rodrigue JR, Paek MJ, Egbuna O, Waterman AD, Schold JD, Pavlakis M, Mandelbrot DA. Readiness to Pursue Live Donor Kidney Transplantation Among Black Patients to Pursue Live Donor Kidney Transplant. Progress in Transplantation. 2014 Dec 24(4): 355-61.
  151. Schold JD. For Kidney Transplant Recipients, Seventy is the New Fifty. Journal of the American Geriatrics Society. 2014 Dec 62(12): 2430-32.
  152. Prakash S, McGrail A, Lewis SA, Schold J, Lawless ME, Sehgal AR, Perzynski AT. Behavioural Stage of Change and Dialysis Modality Decision Making. Clinical Journal of the American Society of Nephrology. 2015 Feb 10(2): 197-204. 
  153. Schold JD, Poggio ED, Goldfarb DA, Kayler LK, Flechner SM. Clinical Outcomes associated with Induction Regimens among Re-transplant Kidney Recipients in the United States. Transplantation (in press).
  154. Schold JD and Nicholas LH. Considering Potential Benefits and Consequences of Hospital Report Cards: What are the Next Steps? Health Services Research (in press).
  155. Rudow DL, Hays R, Baliga P, Cohen DJ, Cooper M, Danovitch GM, Dew MA, Gordon EJ, Mandelbrot DA, McGuire S, Milton J, Moore DR, Morgieivich M, Schold JD, Segev DL, Serur D, Steiner RW, Tan JC, Waterman AD, Zavala EY, Rodrigue JR. Recommendations of the Consensus Conference on Best Practices in Live Kidney Donation. American Journal of Transplantation (in press).
  156. Liu F, Bennett S, Arrigain S, Schold J, Heyka R, McLennan G, Navaneethan S. Patency and Complications of Translumbar Dialysis Catheters. American Society of Diagnostic and Interventional Nephrology (in press).
  157. Schold JD, Buccini LD, Rodrigue JR, Mandelbrot D, Goldfarb DA, Flechner SM, Kayler LK, Poggio ED. Critical Factors associated with Missing Follow-Up Data for Living Kidney Donors in the United States. American Journal of Transplantation (in press).
  158. Dalton JE, Dawson NV, Sessler DI, Schold JD, Love TE, Kattan MW. Empirical Treatment Recommendations for Optimizing Binary Outcomes. Medical Decision Making (in press).
  159. Nakhoul G, Schold J, Arrigain S, Harb S, Jolly S, Wilkoff B, Nally Jr. J, Navaneethan S. Implantable Cardioverter-Defibrillators in Patients with Chronic Kidney Disease: A Propensity-Matched Mortality Analysis. Clinical Journal of Nephrology (in press).
  160. Rodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Madelbrot DA. American Journal of Transplantation (in press).